AVEO Oncology (AVEO) Fails to deliver data

Key failure to deliver metrics for AVEO Oncology :

• Last SEC data release: 2023-12-29
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last year FTD volume: N/A

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AVEO Oncology (AVEO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AVEO Oncology (AVEO) - since 2020

AVEO Oncology (AVEO) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Biogen BIIB	NZ$7.66 M	NZ$69.08 M	🇺🇸 USA
Regeneron Pharmaceuticals REGN	NZ$14.63 M	NZ$0.10 B	🇺🇸 USA
Merrimack Pharmaceuticals MACK	N/A	NZ$4.89 M	🇺🇸 USA
Bristol-Myers Squibb BMY	NZ$29.95 M	NZ$0.31 B	🇺🇸 USA
Eli Lilly LLY	NZ$41.73 M	NZ$0.14 B	🇺🇸 USA
Amgen AMGN	NZ$48.74 M	NZ$0.23 B	🇺🇸 USA